Fibromyalgia
References
Aaron LA, Burke MM, et al. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. 2000 Jan 24;160(2):221-7
Adak B, Tekeoglu I, et al. Fibromyalgia frequency in hepatitis B carriers. J Clin Rheumatol. 2005 Jun;11(3):157-9.
Adler GK, Manfredsdottir VF, et al. Neuroendocrine abnormalities in fibromyalgia. Curr Pain Headache Rep. 2002 Aug;6(4):289-98.
Ataoglu S, Ozcetin A, et al. Evaluation of dexamethasone suppression test in fibromyalgia patients with or without depression. Swiss Med Wkly. 2003 Apr 19;133(15-16):241-4.
Bagis S, Tamer L, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005 Apr;25(3):188-90.
Bennet RM 2002. Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep. 2002 Aug;4(4):306-12. Review.
Bennett R. Fibromyalgia: present to future. Curr Rheumatol Rep. 2005 Oct;7(5):371-6.
Calis M, Gokce C, et al. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest. 2004 Jan;27(1)42-6.
Citera G, Arias MA, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol. 2000;19(1):9-13.
Dessein PH, Shipton EA, et al. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin, and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain. 1999 Nov;83(2):313-9.
Gebhart B, Jorgenson JA. Benefit of ribose in a patient with fibromyalgia. Pharmacotherapy. 2004 Nov;24(11):1646-8.
Geenen R, Jacobs JW, et al. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am. 2002 May;28(2):389-404.
Gerwin RD. A review of myofascial pain and fibromyalgia: factors that promote their persistence. Acupunct Med. 2005 Sep;23(3):121-34. Review.
Goldenberg D. Fibromyalgia. New York, NY: Perigee, Penguin Putnam, Inc; 2002.
Hanninen O, Kaartinen K, et al. Antioxidants in vegan diet and rheumatic disorders. Toxicology. 2000 Nov 30;155(1-3):45-53.
Holdcraft LC, Assefi N, et al. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003 Aug;17(4):667-83. Review.
Kasper DL, Braunwald E, et al. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Medical Publishing Division; 2005.
McIver KL, Evans C, et al. NO-mediated alterations in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain. 2006 Jan;120(1-2):161-9.
Mense S. Neurobiological basis of muscle pain [in German]. Schmerz. 1999 Feb 18;13(1):3-17.
Okifuji A, Turk DC. Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Appl Psychophysiol Biofeedback. 2002 Jun;27(2):129-41. Review.
Ozgocmen S, Ozyurt H, et al. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2005a Nov 10;:1-6.
Ozgocmen S, Ozyurt H, et al. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int. 2005b Nov 20;1-13.
Pall ML. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome, and multiple chemical sensitivity via elevated nitric
oxide/peroxynitrite. Med Hypotheses. 2001 Aug;57(2):139-45. Comment in: Med Hypotheses. 2005c;65(3):631-3.
Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue
syndrome. Med Hypotheses. 2000 Jan;54(1):115-25. Comment in: Med Hypotheses. 2005b;65(3):631-3.
Pall ML. Nitric oxide and the etiology of chronic fatigue syndrome: giving credit where credit is due. Med Hypotheses. 2005a;65(3):631-3.
Park JH, Phothimat P, et al. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum. 1998 Mar;41(3):406-13.
Rohr UD, Herold J. Melatonin deficiencies in women. Maturitas. 2002 Apr 15;41(suppl 1):S85-104. Review.
Schochat T, Beckmann C. Sociodemographic characteristics, risk factors, and reproductive history in subjects with fibromyalgia: results of a population-based case-control study [in German]. Z Rheumatol. 2003 Feb;62(1):46-59.
Stratz T, Fiebich B, et al. Influence of tropisetron on the serum substance P levels in fibromyalgia patients. Scand J Rheumatol Suppl. 2004;119:41-3.
Vecchiet J, Cipollone F, et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003 Jan 2;335(3):151-4.
Wallace D, Wallace J. All About Fibromyalgia. New York, NY: Oxford University Press; 2002.
Wikner J, Hirsch U, et al. Fibromyalgia: a syndrome associated with decreased nocturnal melatonin secretion. Clin Endocrinol (Oxf). 1998 Aug;49(2):179-83.
Wu X, Beecher GR, et al. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem. 2004 Jun 16;52(12): 4026-37.